Lifelines Neuro

Lifelines Neuro operates across medical devices, neurodiagnostics software, and EEG monitoring. Its product range spans portable video EEG for ambulatory monitoring, cart-based systems for routine and long-term monitoring, specialized equipment for ICU, NICU, and emergency settings, and EEG amplifiers. The company also describes cloud-based acquisition and review capabilities, including the Rendr Platform, which could extend access beyond the recording site. This breadth differentiates its stated offering from a profile focused on a single EEG device: it combines hardware, software, and clinical-trial services for different care and research settings. Nor are comparative measures such as installed base, market share, pricing, or clinical outcomes available to substantiate a relative leadership claim. Lifelines Neuro is privately held, with no disclosed valuation or funding history in this profile. Its positioning is therefore best understood through the breadth of its EEG product portfolio and its stated emphasis on usability and remote access, rather than through unsupported competitive or scale claims.

Lifelines Neuro was founded in 1999 and is listed as active, giving it a long operating history compared with an early-stage medical-device venture. Its current product portfolio covers ambulatory video EEG, hospital and critical-care cart systems, amplifiers, cloud software, and EEG clinical-trial services. The company is associated with an employee range of 51–100. Leadership role-start dates include Simon Griffin as Founder and Chairman in 2019, Devin Ferrey as Interim CEO in 2020, and Emerson Ferrey as Chief Operating Officer in 2021. These historical dates do not establish current leadership changes. The clearest observable trajectory is a broadening product and service offering around EEG monitoring.